Helomics® Corporation and Ariel Precision Medicine, Inc. sign a services agreement to Advance Clinical Genomics in Precision Medicine Applications
Furthermore, this agreement solidifies the shared vision of making the
The terms and conditions established between Ariel and Helomics were not disclosed.
Helomics® is a precision diagnostic company and integrated clinical contract research organization whose mission is to improve patient care by partnering with pharmaceutical, diagnostic, and academic organizations to bring innovative clinical products and technologies to the marketplace. In addition to its proprietary precision diagnostics for oncology, Helomics offers boutique CRO services that leverage our patient-derived tumor models, coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and a proprietary bioinformatics platform (D-CHIP) to provide a tailored solution to our client’s specific needs. Helomics has signed a joint venture term sheet with
Helomics® is headquartered in
For more information, please visit: www.Helomics.com.
About Ariel Precision Medicine, Inc.
Ariel is an integrated genomics and digital health company delivering precision medicine solutions enabling the early diagnosis, prognosis and management of complex chronic diseases. Ariel’s technologies can lead a paradigm shift from targeting single gene (Mendelian) genetics to using multifaceted, complicated gene to gene interactions that interface with familial and environmental factors to provide a more comprehensive view of disease trajectory and precise therapeutic options. Results from next generation sequencing of more than 1500 genetic targets are integrated with a patient’s symptoms and complex medical information using systems modeling, machine learning and other advanced reporting technology to create decision support tools. The process compares a patient and his or her disease behavior against databases of well-mapped, complex disease patterns to help determine both the underlying cause of the disease and the optimal treatment plan. Ariel’s headquarters are in
For more information, please visit: www.arielmedicine.com
Source: Skyline Medical Inc.